Real-world evidence of cabozantinib in metastatic renal-cell carcinoma (mRCC): Results from the Canadian Kidney Cancer Information System (CKCis).Han‐Bo Zhang, Jeffrey Graham, Aly‐Khan A. Lalani et al.|Journal of Clinical Oncology|2020Cited by 2
Efficacy of tyrosine kinase inhibitors (TKI) after combination ipilimumab plus nivolumab (I/N) in metastatic clear cell renal cell carcinoma (ccmRCC) patients: Results from the Canadian Kidney Cancer Information System (CKCis).Austin Kalirai, Naveen S. Basappa, Isaiah Joy et al.|Journal of Clinical Oncology|2022Cited by 0